Neuronal differentiation of human mesenchymal stromal cells increases their resistance to Aβ42 aggregate toxicity

Journal of Alzheimer's Disease

Volumn 27, Issue 3, 2011, Pages 651-664

  Cecchi, Cristina ^a   Evangelisti, Elisa ^a   Cascella, Roberta ^a   Zampagni, Mariagioia ^a   Benvenuti, Susanna ^a   Luciani, Paola ^a   Deledda, Cristiana ^a   Cellai, Ilaria ^a   Wright, Daniel ^a   Saccardi, Riccardo ^b   Peri, Alessandro ^a   Stefani, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Amyloid; amyloid toxicity; calcium dysregulation; GM1; oxidative stress; stem cells

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; GANGLIOSIDE GM1;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYME CELL; NERVE CELL DIFFERENTIATION; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STROMA CELL;

EID: 82555184968     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110590     Document Type: Article

References (57)

1. Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3, 75-80.
2. Dobson CM (2003) Protein folding and misfolding. Nature 18, 884-890. (Pubitemid 38056880)
3. Stefani M, DobsonCM(2003) Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81, 678-699. (Pubitemid 37491594)
4. Citron M,Westaway D, XiaW, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodensko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George-Hyslop P, Selkoe DJ (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3, 67-72. (Pubitemid 27019143)
5. Takeda K, Araki W, Tabira T (2004) Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci 19, 258-264. (Pubitemid 38177864)
6. Tabaton M, Tamagno E (2007) The molecular link between beta- and gamma-secretase activity on the amyloid beta precursor protein. Cell Mol Life Sci 64, 2211-2218. (Pubitemid 47347960)
7. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185.
8. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, KleinWL(1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 6448-6453.
9. Tomic JL, Pensalfini A, Head E, Glabe CG (2009) Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis 35, 352-358.
10. Stefani M (2007) Generic cell dysfunction in neurodegenerative disorders: Role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity. Neuroscientist 13, 519-531. (Pubitemid 47437929)
11. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7, 548-554. (Pubitemid 33127140)
12. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300. (Pubitemid 41389198)
13. Rando TA (2006) Stem cells, ageing and the quest for immortality. Nature 441, 1080-1086. (Pubitemid 43990720)
14. Tang J, Xu H, Fan X, Li D, Rancourt D, Zhou G, Li Z, Yang L (2008) Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Abeta(1-40) injured rats. Neurosci Res 62, 86-96.
15. Dantuma E, Merchant S, Sugaya K (2010) Stem cells for the treatment of neurodegenerative diseases. Stem Cell Res Ther 1, 37-43.
16. Zhao C, DengW, GageFH(2008) Mechanisms and functional implications of adult neurogenesis. Cell 132, 645-660. (Pubitemid 351253687)
17. Sugaya K, Alvarez A, Marutle A, Kwak YD, Choumkina E (2006) Stem cell strategies for Alzheimer's disease therapy. anminerva Med 48, 87-96. (Pubitemid 44671264)
18. Kwak YD, Brannen CL, Qu T, Kim HM, Dong X, Soba P, Majumdar A, Kaplan A, Beyreuther K, Sugaya K (2006) Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev 15, 381-389. (Pubitemid 44100015)
19. Manutle A, Ohmitsu M, Nilbratt M, Greig NH, Nerdberg A, Sugaya K (2007) Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proc Natl Acad Sci U S A 104, 12506-12511. (Pubitemid 47206168)
20. Cecchi C, Baglioni S, Fiorillo C, Pensalfini A, Liguri G, Nosi D, Rigacci S, Bucciantini M, Stefani M (2005) Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J Cell Sci 118, 3459-3470. (Pubitemid 41246100)
21. Cecchi C, Pensalfini A, Stefani M, Baglioni S, Fiorillo C, Cappadona S, Caporale R, Nosi D, Ruggiero M, Liguri G (2008) Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity. J Mol Med 86, 197-209. (Pubitemid 351172125)
22. Cecchi C, Pensalfini A, Liguri G, Baglioni S, Fiorillo C, Guadagna S, Zampagni M, Formigli L, Nosi D, Stefani M (2008) Differentiation increases the resistance of neuronal cells to amyloid toxicity. Neurochem Res 33, 2516-2531.
23. Molander-Melin M, Blennow K, Bogdanovic N, Dellheden B, Månsson JE, Fredman P (2005) Structural membrane alterations in Alzheimer brains found to be associated with regional disease development, increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J Neurochem 92, 171-182. (Pubitemid 40193519)
24. Yamamoto N, Matsubara T, Sato T, Yanagisawa K (2008) Age-dependent high density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloidβ-protein fibrillogenesis. Biochim Biophys Acta 1778, 2717-2726.
25. Okada T, Ikeda M, Wakabayashi M, Ogawa M, Matsuzaki K (2008) Formation of toxic Aβ(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: Polymorphisms in Aβ(1-40) fibrils. J Mol Biol 382, 1066-1074.
26. Ariga T, McDonald MP, Yu RK (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review. J Lipid Res 49, 1157-1175.
27. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, VerfaillieCM(2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49. (Pubitemid 34742565)
28. Lie DC, Song H, Colamarino SA, Ming GL, Gage FH (2004) Neurogenesis in the adult brain: New strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44, 399-421. (Pubitemid 38263847)
29. Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Venton DL, Krafft GA, Finch CE, Klein WL (2001) Vaccination with soluble Abeta oligomers generates toxicityneutralizing antibodies. J Neurochem 79, 595-605. (Pubitemid 33029933)
30. Cecchi C, Nichino D, Zampagni M, Bernacchioni C, Evangelisti E, Pensalfini A, Liguri G, Gliozzi A, Stefani M, Relini A (2009) A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. Biochim Biophys Acta 1788, 2204-2216.
31. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and Fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277, 32046-32053. (Pubitemid 34969015)
32. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda C, Cellai I, Francini F, Squecco R, Rosati F, Danza G, Gelmini S, Greeve I, Rossi M, Maggi R, Serio M, Peri A (2006) Neuronal differentiation of human mesenchymal stem cells: Changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp Cell Res 312, 2592-2604. (Pubitemid 44055932)
33. Dal Pozzo S, Urbani S, Mazzanti B, Luciani P, Deledda C, Lombardini L, Benvenuti S, Peri A, Bosi A, Saccardi R (2010) High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow. Cytotherapy 12, 579-586.
34. Bradford MM (1976) A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
35. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP (1997) A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253, 162-168. (Pubitemid 27508167)
36. Kinoshita A, Fukumoto H, Shah T, Whelan CM, Irizarry MC, Hyman BT (2003) Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci 116, 3339-3346. (Pubitemid 37038982)
37. Arispe N, Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J 16, 1526-1536. (Pubitemid 35154635)
38. Orrenius S, Zhovotovsky B, Nicotera P (2003) Regulation of cell death: The calcium-apoptosis link. Nat Rev 4, 552-565. (Pubitemid 36773407)
39. Canale C, Torrassa S, Rispoli P, Relini A, Rolandi R, Bucciantini M, Stefani M, Gliozzi A (2006) Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers. Biophys J 91, 4575-4588. (Pubitemid 44904242)
40. Lovell MA, Markesbery WR (2006) Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Curr Alzheimer Res 3, 359-364. (Pubitemid 44351479)
41. Cecchi C, Rosati F, Pensalfini A, Formigli L, Nosi D, Liguri G, Dichiara F, Morello M, Danza G, Pieraccini G, Peri A, Serio M, Stefani M (2008) Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. J Cell Mol Med 12, 1990-2002.
42. Lee IP,McKenzie S, Muller FJ, SnyderEY(2008) Neural stem cell transplantation in mouse brain. Curr Protoc Neurosci Chapt. 3, Unit 3.10.
43. Pearson XH, Teng YD, Snyder EY (2008) Important precautions when deriving patient-specific neural elements from pluripotent cells. Cytotherapy 11, 815-824.
44. Martins IC, Kuperstein I, Wilkinson H, Maes E, Vanbrabant M, Jonckheere W, Van Gelder P, Hartmann D, D'Hooge R, De Strooper B, Schymkowitz J, Rousseau F (2008) Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J 27, 224-233.
45. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, LeeVM,HymanBT, Spires-JonesTL(2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 106, 4012-4017.
46. Yankner BA, Duffy LK, Kinschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science 250, 279-282.
47. López-ToledanoMA,ShelanskiML(2004) Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. J Neurosci 24, 5439-5444. (Pubitemid 38747685)
48. Eucher JN, Uemura E, Sakaguchi DS, Greenlee MH (2007) Amyloid-beta peptide affects viability but not differentiation of embryonic and adult rat hippocampal progenitor cells. Exp Neurol 203, 486-492. (Pubitemid 46149594)
49. Neri T, Bucciantini M, Rosti V, Raimondi S, Relini A, Massa M, Zuccotti M, Donadei S, Stefani M, Redi CA, Merlini G, Stoppini M, Garagna S, BellottiV(2010) Embryonic stem and haematopoietic progenitor cells resist toAβ oligomer toxicity and maintain the differentiation potency in culture. Amyloid 17, 137-145.
50. Haughey NJ, Liu D, Nath A, Borchard AC, Mattson MP (2002) Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: Implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med 1, 125-135. (Pubitemid 37012521)
51. Mazur-Kolecka B, Golabek A, Nowicki K, Flory M, Frackowiak J (2006) Amyloid-beta impairs development of neuronal progenitor cells by oxidative mechanisms. Neurobiol Aging 27, 1181-1192. (Pubitemid 44067306)
52. Malchiodi-Albedi F, Contrusciere V, Raggi C, Fecchi K, Rainaldi G, Paradisi S, Matteucci A, Santini MT, Sargiacomo M, Frank C, Gaudiano MC, Diociaiuti M (2010) Lipid raft disruption protects mature neurons against amyloid oligomer toxicity. Biochim Biophys Acta 1802, 406-415.
53. Herrup KJ (2010) Re-imagining Alzheimer's disease - an agebased hypothesis. J. Neurosci 30, 16755-16762.
54. BeroAW,Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, HoltzmanDM(2011) Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat Neurosci 14, 750-756.
55. Barnett A, Brewer GJ (2011) Autophagy in aging and Alzheimer's disease: Pathologic or protective? J Alzheimers Dis 25, 385-394.
56. Yanagisawa M, Ariga T, Yu RK (2010) Cytotoxic effects of G(M1) ganglioside and amyloid beta-peptide on mouse embryonic neural stem cells. ASN Neuro 152(1), e00029.
57. Jan A, Gokce O, Luthi-Carter R, LashuelHA(2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283, 28176-28189.